Mohammad Abul Kalam Azad

Prof. Dr. Mohammad Abul Kalam Azad

Rheumatology, Professor of Rheumatology, Bangladesh Medical University, Bangladesh, Dhaka, Bangladesh
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2020 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
TMTarek Mahmood
Tarek Mahmood
MCMinhaj Rahim Choudhury
Minhaj Rahim Choudhury
MIMd Nazrul Islam
Md Nazrul Islam
SHSyed Atiqul Haq
Syed Atiqul Haq
ASAbu Shahin
Abu Shahin
Johannes J RaskerJohannes J Rasker
Johannes J Rasker
Background: This study was focused on translation and cultural adaptation of the English Lequesne Algofunctional index (LAI) into Bengali for patients with primary knee osteoarthritis (OA) and testing reliability and validity of the Bengali version of the LAI. Methods: This study was carried out in the Department of Rheumatology, BSM Medical University, Dhaka, Bangladesh. Using the forward–backward method the English LAI was translated into Bengali including cultural adaptation. For pretesting, A sample of 40 patients with primary knee osteoarthritis were screened using the Bengali version of LAI. Following the pretest, 130 consecutive patients with symptomatic knee OA completed the interviewer administered Bengali LAI, the validated Bengali version of SF-36, Visual Analogue Scale for Pain, Distance Walked and Activities of Daily Living. For the retest 60 randomly selected patients from the cohort were administered the Bengali LAI 7 days later. An item by item analysis was performed. Internal consistency was assessed by Cronbach’s alpha, test–retest reliability by intraclass correlation coefficient (ICC) and Kappa coefficient, construct validity was measured using the Spearman rank correlation coefficient. Results: It took 3.25 ± 0.71 min to complete the Bengali LAI and the mean score was 9.23 ± 4.58. For the Bengali LAI Cronbach’s alpha score was 0.88, test–retest reliability assessed by ICC was 0.97. For construct validity, excellent convergent validity was achieved (ρ = 0.93) but the divergent validity was moderate (ρ = 0.43). Conclusions: The Bengali LAI showed excellent convergent validity, internal consistency and test–retest reliability, only the divergent validity was moderate. So, the Bengali LAI can be applied as a HRQoL assessment tool for primary knee OA patients.

23 July 2025 in Cureus
Verified
Journal Article
Open access
PDF file
Mohammad Abul Kalam AzadMohammad Abul Kalam Azad
Mohammad Abul Kalam Azad
AAAkash Ahmed Alif
Akash Ahmed Alif
NMNayan Kumar Mallik
Nayan Kumar Mallik
SNSharmin Nahar
Sharmin Nahar
AAAbul Khair Ahmedullah
Abul Khair Ahmedullah
AUAbul Khair Ahmed Ullah
Abul Khair Ahmed Ullah
Systemic lupus erythematosus (SLE) is a long-term autoimmune disorder that affects multiple organ systems and presents with a broad spectrum of symptoms, ranging from mild, nonspecific complaints to severe, potentially life-threatening complications. It is commonly seen in females but may occur in males. Ocular involvement is common in SLE patients. These ophthalmic symptoms can develop during the course of the disease or may be the initial sign. Although rare, sudden vision loss due to retinal vessel involvement can be the first presentation of SLE. This case series highlights a rare manifestation of SLE bilateral retinal vasculitis as either the initial or subsequent presentation of the disease. The mean age with standard deviation of the patients in this series was 29.67±9.44​ years. Of the three patients, one was male and two were female. In one case, retinal vasculitis was the initial manifestation of SLE, while in the other two, it developed during the disease. All patients were treated with intravenous methylprednisolone (MP), followed by oral prednisolone at a dose of 1 mg/kg of body weight, in combination with monthly cyclophosphamide. Partial clinical improvement was observed in all cases. Retinal vasculitis, whether isolated or accompanied by involvement of other organs, should be considered in the differential diagnosis of visual disturbances in SLE patients. Early recognition and prompt treatment are critical to prevent irreversible retinal damage and complications

7 October 2025 in Cureus
Verified
Journal Article
Open access
PDF file
ATAbdul Mahin Tazbir
Abdul Mahin Tazbir
Mohammad Abul Kalam AzadMohammad Abul Kalam Azad
Mohammad Abul Kalam Azad
AAAbul Khair Ahmedullah
Abul Khair Ahmedullah
MHM Masudul Hassan
M Masudul Hassan
FNFahmida Nishu
Fahmida Nishu
ATAbdul Tazbir
Abdul Tazbir
Objectives The objective was to evaluate the efficacy and safety of escalating tofacitinib from 10 mg to 15 mg daily in NSAID-refractory axial spondyloarthritis (ax-SpA) patients with inadequate 12-week response to 10 mg. Methods This was a pragmatic, open-label, single-arm, dose-escalation study (24 weeks). 101 patients were enrolled (ITT); 88 completed both week-12 and week-24 assessments (evaluable). All started tofacitinib 10 mg daily. At week 12, those achieving ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score - C-reactive protein) major improvement (MI; Δ≥2.0) continued 10 mg; non-responders escalated to 15 mg. Outcomes included ASDAS-CRP (Clinically Important Improvement (CII)/MI/inactive disease), Assessment of SpondyloArthritis International Society criteria (ASAS 20/40), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Ankylosing Spondylitis Quality of Life (ASQoL), and 36-Item Short-Form Health Survey (SF-36); safety was monitored per Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Results Of the evaluable cohort (n=88), 57 (64.8%) achieved MI at week 12 and continued 10 mg; 31 (35.2%) escalated to 15 mg. By week 24, mean ASDAS-CRP improved from 4.4→1.7 (10 mg) and 4.0→2.2 (15 mg). In the escalation subgroup, ASDAS-CRP improved 3.0 ± 0.7→2.2 ± 0.7, BASDAI 3.9 ± 1.3→2.9 ± 1.2, and ASAS 20/40 responses rose to 93.5%/45.2%. Six patients discontinued due to AEs (5 transaminitis at ≤10 mg; 1 breast tumour). Rhinitis was more frequent with 15 mg (58.1% vs 31.6%). No TB, VTE, MACE, or deaths occurred. Conclusions In patients not meeting 12-week targets on 10 mg, escalation to 15 mg yielded additional clinically meaningful improvement with a safety profile generally comparable to 10 mg. Selective escalation may be a feasible treat-to-target strategy where alternatives are limited.

20 March 2025 in Cureus
Verified
Journal Article
Open access
PDF file
SSShadab Saud Sunny
Shadab Saud Sunny
Mohammad Abul Kalam AzadMohammad Abul Kalam Azad
Mohammad Abul Kalam Azad
MHM Masudul Hassan
M Masudul Hassan
AAAtm Asaduzzaman
Atm Asaduzzaman
NINazrul Islam
Nazrul Islam
Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. Sometimes vasculitis may complicate the disease. Among the manifestations of SLE, vasculitis presentation is common. This study aimed to identify the predictors of vasculitis in SLE patients. Methods This is a cross-sectional study in a single center conducted in the Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from December 2019 to January 2021. The disease activity and damage were assessed using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index (SLICC/ACR DI). Study subjects were grouped into vasculitis and no vasculitis groups. The multivariate logistic regression analysis was done to determine the independent predictors of vasculitis in SLE. The p-value <0.05 was considered significant. Results The rate of lupus vasculitis was 14.3%. The significant difference in vasculitis features between vasculitis and no vasculitis groups were: acute cutaneous lupus erythematosus (ACLE) (p<0.001), oral ulcer (p<0.001), alopecia (p<0.001), Raynaud’s phenomenon (p=0.011), fever (p=0.002), arthritis (p<0.001), pregnancy loss (p=0.003), lupus nephritis (p=0.032), seizure (p=0.027), pleurisy (p=0.027), leucopenia (p=0.049), anti-dsDNA positivity (p=0.008), hypocomplementemia (p=0.003), higher mean SLEDAI (p<0.001) and SLICC/ACR DI score (p<0.001). In multivariate logistic regression analysis, higher SLEDAI score (OR = 1.296, 95% CI =1.114-1.508) was positively and lupus nephritis (OR= 0.055, 95% CI =0.007-0.413) was negatively associated with lupus vasculitis. Conclusion The vasculitis flare of lupus is associated with Raynaud’s phenomenon and pregnancy loss. Mucocutaneous flare, fever, arthritis, seizure, pleurisy, and lupus nephritis were also associated with vasculitis.

17 June 2025 in Cureus
Verified
Journal Article
Open access
PDF file
AAA F M Mahbubul Alam
A F M Mahbubul Alam
Mohammad Abul Kalam AzadMohammad Abul Kalam Azad
Mohammad Abul Kalam Azad
MHM Masudul Hassan
M Masudul Hassan
SISajeda Islam
Sajeda Islam
NINazrul Islam
Nazrul Islam
SHSyed Atiqul Haq
Syed Atiqul Haq
Background: The present study aimed to determine the efficacy and safety of thalidomide compared to sulfasalazine (SSZ) in moderate to severe cases of ankylosing spondylitis (AS) in Bangladesh. Methods: This experimental study was conducted from January 2017 to December 2018 in the Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. The experimental study included 93 adult patients with moderate to severe AS (47 received thalidomide, and 46 received SSZ). Change in disease status was considered an efficacy endpoint, while the prevalence of adverse events was considered a safety endpoint. Results: Thalidomide showed better efficacy compared to SSZ in terms of disease activity index (Bath Ankylosing Spondylitis Disease Activity Index) (2.84 vs. 4.49, p < 0.001). Secondary endpoints such as functional index (Bath Ankylosing Spondylitis Functional Index) (2.32 vs. 3.34, p = 0.021), patients’ global assessment (2.92 vs. 4.11, p < 0.001), physician global assessment (2.67 vs. 3.60, p < 0.001), spinal pain score (2.52 vs. 3.31, p = 0.025), swollen joint count (0.05 vs. 0.40, p < 0.001), morning stiffness (2.08 vs. 3.27, p < 0.001), erythrocyte sedimentation rate (28.17 mm vs. 34.25 mm, p = 0.023), and C-reactive protein (9.57 mg/l vs. 21.34 mg/l, p = 0.027) were also better in the thalidomide group. Moreover, a significantly higher number of patients achieved 40% improvement in the thalidomide group compared to the SSZ group (90% vs. 10%, p < 0.001). Pedal edema was the most common adverse event (16, 46%) in the thalidomide group, followed by somnolence (13, 37%), drowsiness (12, 34%), dry mouth (11, 31%), and skin rash (11, 31%). On the other hand, anorexia (17, 48%), headache (15, 43%), and gastric irritation (10, 28%) were common adverse events in the SSZ group. Conclusion: Despite a few mild side effects, thalidomide is effective and safe in comparison with SSZ for treating patients with moderate to severe AS for short-term assessment.

27 June 2025 in Cureus
Verified
Journal Article
Open access
PDF file
Mohammad Abul Kalam AzadMohammad Abul Kalam Azad
Mohammad Abul Kalam Azad
MHM Masudul Hassan
M Masudul Hassan
MCMinhaj Rahim Choudhury
Minhaj Rahim Choudhury
AIAriful Islam
Ariful Islam
AAAbul Khair Ahmedullah
Abul Khair Ahmedullah
Ultrasound-guided synovial biopsy (USG-SB) is a minimally invasive technique useful in diagnosing joint tuberculosis, particularly when conventional methods fail. However, its role in diagnosing tubercular arthritis in Bangladesh remains underexplored. This study presents a case series of five patients with monoarthritis - three with ankle involvement and two with knee joint tuberculosis - evaluated using USG-SB or aspiration. The procedures were performed using a high-resolution musculoskeletal ultrasound (14-6 MHz probe, Mindray, Shenzhen, China). Synovial tissue samples were analyzed via histopathology and GeneXpert (Cepheid, Sunnyvale, California, US) testing, while synovial fluid was examined via cytology, acid-fast bacilli (AFB) staining, and GeneXpert. Tuberculosis was confirmed histologically in three cases, GeneXpert was positive in two, and AFB staining was positive in one. These findings support USG-SB as a safe, effective, and minimally invasive diagnostic option for tubercular arthritis, particularly in resource-limited settings like Bangladesh.